Ricardo Martins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ricardo Martins has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- José Guilherme Tralhão
General Surgey Department, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal
4 shared publications - Rui Caetano Oliveira
Centro de Investigação em Meio Ambiente, Genética e Oncobiologia—CIMAGO, Faculdade de Medicina, Universidade de Coimbra, 3004-535 Coimbra, Portugal
4 shared publications - Maria Augusta Cipriano
Department of Pathology, Unidade Local de Saúde de Coimbra, Coimbra, Portugal
3 shared publications - Henrique Alexandrino
Department of General Surgery, Faculty of Medicine, Coimbra University Hospital Center, University of Coimbra, Coimbra, Portugal
2 shared publications - Ana Margarida Abrantes
Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal
1 shared publication - André Pinho
Dermatology and Venereology Department Unidade Local de Saúde de Coimbra Coimbra Portugal
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
- Vol. 33 (1) , 470-475
Segmental Cholangiectasia of the Intrahepatic Bile Duct: A Case Report
Introduction: Segmental cholangiectasia is a rare cause of focal intrahepatic bile duct dilatation that can mimic congenital, inflammatory, or neoplastic conditions, posing diagnostic challenges. Case Presentation: We describe a 58-year-old man with a longstanding cystic lesion in hepatic segment 8 who developed multiple cholangitic episodes. Despite the exclusion of infectious, autoimmune, and overt neoplastic disease, an elevated carbohydrate antigen 19-9 (CA 19-9) raised concern for intraductal papillary neoplasm of the bile duct and prompted anterior hepatic sectorectomy. Histopathology confirmed segmental cholangiectasia, showing ductal dilatation, bile stasis, cholesterol clefts, fibrosis, and mixed inflammation, without evidence of malignancy or IgG4-related disease. Discussion and Conclusion: Segmental cholangiectasia is a benign yet clinically significant entity that can mimic biliary tumors and prompt major surgery. This case, involving hepatic segment 8, expands the known anatomical spectrum and underscores the importance of multidisciplinary evaluation. Awareness of this condition may prevent misdiagnosis and guide appropriate management, while further studies are needed to better characterize its presentation in Western populations.
- 1 January 2026
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
- Vol. 33 (1) , 470-475
Open AccessSegmental Cholangiectasia of the Intrahepatic Bile Duct: A Case Report
Introduction: Segmental cholangiectasia is a rare cause of focal intrahepatic bile duct dilatation that can mimic congenital, inflammatory, or neoplastic conditions, posing diagnostic challenges. Case Presentation: We describe a 58-year-old man with a longstanding cystic lesion in hepatic segment 8 who developed multiple cholangitic episodes. Despite the exclusion of infectious, autoimmune, and overt neoplastic disease, an elevated carbohydrate antigen 19-9 (CA 19-9) raised concern for intraductal papillary neoplasm of the bile duct and prompted anterior hepatic sectorectomy. Histopathology confirmed segmental cholangiectasia, showing ductal dilatation, bile stasis, cholesterol clefts, fibrosis, and mixed inflammation, without evidence of malignancy or IgG4-related disease. Discussion and Conclusion: Segmental cholangiectasia is a benign yet clinically significant entity that can mimic biliary tumors and prompt major surgery. This case, involving hepatic segment 8, expands the known anatomical spectrum and underscores the importance of multidisciplinary evaluation. Awareness of this condition may prevent misdiagnosis and guide appropriate management, while further studies are needed to better characterize its presentation in Western populations.
- Open Access
- 30 September 2024
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
- Vol. 38 (3) , 241-245
Hepatocellular carcinoma associated with progressive intrahepatic familial cholestasis type 2: a case report
João Miguel Pimentel, Susana Nobre, Rui Caetano Oliveira, Ricardo Martins, Maria Augusta Cipriano. Clin Transplant Res 2024;38:241-5. https://doi.org/10.4285/ctr.24.0016
- 30 September 2024
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
- Vol. 38 (3) , 241-245
Open AccessHepatocellular carcinoma associated with progressive intrahepatic familial cholestasis type 2: a case report
João Miguel Pimentel, Susana Nobre, Rui Caetano Oliveira, Ricardo Martins, Maria Augusta Cipriano. Clin Transplant Res 2024;38:241-5. https://doi.org/10.4285/ctr.24.0016
- Open Access
- 15 April 2024
- Published by MDPI AG in Gastrointestinal Disorders
- Vol. 6 (2) , 402-420
Prognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping
Introduction: Hepatectomy (HP) is, along with liver transplantation, the only potentially curative treatment for Hepatocellular Carcinoma (HCC). The high prevalence of Metabolic Syndrome (MS) may be causing a shift in the HCC spectrum. Hepatic Pedicle Clamping (HPC), used to reduce perioperative bleeding during HP, has been theorized to increase the risk of recurrence. Cytokeratin 19 (CK19) and glypican-3 (GLP-3) have been identified as markers of worse prognosis in HCC. Materials and Methods: A clinical and pathological review of 59 patients undergoing HP for HCC between 2005 and 2013 was performed. Chronic liver disease was observed in 53 patients (89.8%), with cirrhosis in 54.2% [most frequent etiologies: ethylism (47.5%), HCV (25.4%) and HBV (11.9%)]. MS was in 36% of patients. In addition, 95% of patients had Child–Pugh class A and 5% class B, and there was a median MELD of 8 (6–18). A single nodule was observed in 46 patients (78%) with an average size of 5.4 cm. Microscopic vascular invasion (MiVI) was in 49% of patients and macroscopic (MaVI) in 17. HPC was in 43 patients (74.1%). Statistical analysis was performed with SPSS™ 21.0. Survival tests (Kaplan–Meier, log-rank and Cox regression). Statistical significance was with p < 0.05. Results: Major morbidity in 22% of patients. Mortality in 5.1%. Median overall survival (OS) of 71 months and median disease-free survival (DFS) of 37. In a multivariate analysis: MaVI (p = 0.001), MiVI (p = 0.005) and HCV infection (p = 0.002) were associated with worse OS; MS was associated with better OS (p = 0.001); MaVI (p = 0.000), MiVI (p = 0.035) and HPC (p = 0.012) were associated with worse DFS. CK19+/GLP-3− (p = 0.007) and CK19−/GLP-3+ (p = 0.029) patients were associated with worse DFS and CK19−/GLP-3− (p = 0.031) with better DFS. Discussion/Conclusions: HPC was an independent factor of worse DFS. The ischemia-reperfusion injury (IRI) produced by HPC could promote a more angiogenic and angioinvasive phenotype of tumor cells, resulting in higher recurrence. HCV etiology was associated with worse OS. MS was associated with better OS, highlighting the importance of a hepatectomy in these cases. The combined detection of CK19 and GLP-3 was an independent prognostic factor in HCC patients allowing for the identification of more aggressive tumors.
- 15 April 2024
- Published by MDPI AG in Gastrointestinal Disorders
- Vol. 6 (2) , 402-420
Open AccessPrognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping
Introduction: Hepatectomy (HP) is, along with liver transplantation, the only potentially curative treatment for Hepatocellular Carcinoma (HCC). The high prevalence of Metabolic Syndrome (MS) may be causing a shift in the HCC spectrum. Hepatic Pedicle Clamping (HPC), used to reduce perioperative bleeding during HP, has been theorized to increase the risk of recurrence. Cytokeratin 19 (CK19) and glypican-3 (GLP-3) have been identified as markers of worse prognosis in HCC. Materials and Methods: A clinical and pathological review of 59 patients undergoing HP for HCC between 2005 and 2013 was performed. Chronic liver disease was observed in 53 patients (89.8%), with cirrhosis in 54.2% [most frequent etiologies: ethylism (47.5%), HCV (25.4%) and HBV (11.9%)]. MS was in 36% of patients. In addition, 95% of patients had Child–Pugh class A and 5% class B, and there was a median MELD of 8 (6–18). A single nodule was observed in 46 patients (78%) with an average size of 5.4 cm. Microscopic vascular invasion (MiVI) was in 49% of patients and macroscopic (MaVI) in 17. HPC was in 43 patients (74.1%). Statistical analysis was performed with SPSS™ 21.0. Survival tests (Kaplan–Meier, log-rank and Cox regression). Statistical significance was with p < 0.05. Results: Major morbidity in 22% of patients. Mortality in 5.1%. Median overall survival (OS) of 71 months and median disease-free survival (DFS) of 37. In a multivariate analysis: MaVI (p = 0.001), MiVI (p = 0.005) and HCV infection (p = 0.002) were associated with worse OS; MS was associated with better OS (p = 0.001); MaVI (p = 0.000), MiVI (p = 0.035) and HPC (p = 0.012) were associated with worse DFS. CK19+/GLP-3− (p = 0.007) and CK19−/GLP-3+ (p = 0.029) patients were associated with worse DFS and CK19−/GLP-3− (p = 0.031) with better DFS. Discussion/Conclusions: HPC was an independent factor of worse DFS. The ischemia-reperfusion injury (IRI) produced by HPC could promote a more angiogenic and angioinvasive phenotype of tumor cells, resulting in higher recurrence. HCV etiology was associated with worse OS. MS was associated with better OS, highlighting the importance of a hepatectomy in these cases. The combined detection of CK19 and GLP-3 was an independent prognostic factor in HCC patients allowing for the identification of more aggressive tumors.
- Open Access
- 1 January 2021
- Published by XMLink in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 24 (6) , 528-534
Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
Dos Santos JP, et al. Pediatr Gastroenterol Hepatol Nutr. 2021 Nov;24(6):528-534. https://doi.org/10.5223/pghn.2021.24.6.528
- 1 January 2021
- Published by XMLink in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 24 (6) , 528-534
Open AccessDonor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
Dos Santos JP, et al. Pediatr Gastroenterol Hepatol Nutr. 2021 Nov;24(6):528-534. https://doi.org/10.5223/pghn.2021.24.6.528
- 14 May 2020
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 25 (3) , 698-707
Morphophenotypic Classification of Hepatocellular Carcinoma: the Biliary/Stem Cell Subgroup and Worst Outcome—Implications on Patient Selection
- 14 May 2020
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 25 (3) , 698-707
Morphophenotypic Classification of Hepatocellular Carcinoma: the Biliary/Stem Cell Subgroup and Worst Outcome—Implications on Patient Selection
- Open Access
- 27 February 2014
- Published by BMJ in BMJ Case Reports
- Vol. 2014
Solitary necrotic nodule of the liver: a very challenging diagnosis!
Solitary necrotic nodule of the liver is a rare entity of unknown aetiology. We describe the case of a 59-year-old woman reporting sporadic right upper quadrant pain. An abdominal CT scan revealed a liver nodule located in segment 4. The complementary investigation was unable to identify the neoplastic lesion, and its surgical resection was performed, with an uneventful recovery. Pathological examination revealed a ‘solitary necrotic nodule of the liver.’ The patient remains asymptomatic and free of recurrence 3 years after surgery. This case corroborates that despite the advances in liver imaging and biopsy, liver nodules are sometimes a diagnostic challenge; quite often, only its surgical resection allows a definitive diagnosis.
- 27 February 2014
- Published by BMJ in BMJ Case Reports
- Vol. 2014
Open AccessSolitary necrotic nodule of the liver: a very challenging diagnosis!
Solitary necrotic nodule of the liver is a rare entity of unknown aetiology. We describe the case of a 59-year-old woman reporting sporadic right upper quadrant pain. An abdominal CT scan revealed a liver nodule located in segment 4. The complementary investigation was unable to identify the neoplastic lesion, and its surgical resection was performed, with an uneventful recovery. Pathological examination revealed a ‘solitary necrotic nodule of the liver.’ The patient remains asymptomatic and free of recurrence 3 years after surgery. This case corroborates that despite the advances in liver imaging and biopsy, liver nodules are sometimes a diagnostic challenge; quite often, only its surgical resection allows a definitive diagnosis.